AMA Publishing Group: Targeted and Immune Cancer Therapy Topic Collection
//www.igerbera.com
en - us
Thu, 05 Jan 2023 00:00:00 GMT
Thu, 05 Jan 2023 11:52:46 GMT
Silverchair
jamams@jamanetwork.org
support@www.igerbera.com
-
CAR T Cells for Myeloma and Equal Opportunity—A Call for Equal Opportunity
//www.igerbera.com/journals/jamaoncology/fullarticle/2800241
Thu, 05 Jan 2023 00:00:00 GMT
This Viewpoint examines the equity of US Food and Drug Administration approval and the clinical distribution of chimeric antigen receptor T-cell therapy for patients with multiple myeloma.
10.1001/jamaoncol.2022.6834
2800241
-
Outcomes in Patients with Locally Advanced NSCLC Treated With Chemoradiation and Durvalumab
//www.igerbera.com/journals/jamanetworkopen/fullarticle/2800082
Thu, 05 Jan 2023 00:00:00 GMT
This cohort study evaluates whether tumor mutational burden or other variants associated with radiation response are also associated with outcomes following definitive chemoradiation and adjuvant durvalumab among patients with locally advanced unresectable non–small cell lung cancer (NSCLC).
6
1
e2249591
10.1001/jamanetworkopen.2022.49591
2800082
-
Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma
//www.igerbera.com/journals/jamanetworkopen/fullarticle/2800081
Thu, 05 Jan 2023 00:00:00 GMT
This cross-sectional study analyzes genomic data to examine the presence of actionable alterations in Merkel cell carcinoma in association with tumor mutation burden.
6
1
e2249674
10.1001/jamanetworkopen.2022.49674
2800081
-
Effect of NPC-1C Administered With Second-Line Gemcitabine and Nab-Paclitaxel on Patients With PDAC
//www.igerbera.com/journals/jamanetworkopen/fullarticle/2800079
Thu, 05 Jan 2023 00:00:00 GMT
This randomized clinical trial investigates whether NPC-1C, an antibody directed against MUC5AC, might increase the efficacy of second-line gemcitabine and nab-paclitaxel in patients with advanced pancreatic ductal adenocarcinoma (PDAC).
6
1
e2249720
10.1001/jamanetworkopen.2022.49720
2800079
-
Testing Pleural and Pericardial Effusion for EGFR Variants in Non–Small Cell Lung Cancer
//www.igerbera.com/journals/jamaoncology/fullarticle/2800135
Thu, 29 Dec 2022 00:00:00 GMT
在中国这个诊断研究的患者ssesses the accuracy of droplet digital polymerase chain reaction testing of cell-free DNA from pleural and pericardial effusion in detecting EGFR variants in patients with advanced non–small cell lung cancer.
10.1001/jamaoncol.2022.6109
2800135
-
Trends in the Characteristics, Treatment, and Outcomes of Rectal Adenocarcinoma, 2004 to 2019
//www.igerbera.com/journals/jamaoncology/fullarticle/2800128
Thu, 29 Dec 2022 00:00:00 GMT
This case series uses data from the National Cancer Database to evaluate trends in the characteristics, treatment, and outcomes of rectal adenocarcinoma in the US from 2004 to 2019.
10.1001/jamaoncol.2022.6116
2800128
-
Therapeutic Cancer Vaccines for Recurrent and Metastatic Head and Neck Cancer
//www.igerbera.com/journals/jamaotolaryngology/fullarticle/2799842
Thu, 29 Dec 2022 00:00:00 GMT
This review provides an overview of the clinical efficacy of various treatment modalities currently available for treatment of recurrent and metastatic head and neck squamous cell carcinoma.
10.1001/jamaoto.2022.4264
2799842